These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19404387)

  • 1. A conserved multi-gene family induces cross-reactive antibodies effective in defense against Plasmodium falciparum.
    Singh S; Soe S; Weisman S; Barnwell JW; Pérignon JL; Druilhe P
    PLoS One; 2009; 4(4):e5410. PubMed ID: 19404387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.
    Deshmukh A; Chourasia BK; Mehrotra S; Kana IH; Paul G; Panda A; Kaur I; Singh SK; Rathore S; Das A; Gupta P; Kalamuddin M; Gakhar SK; Mohmmed A; Theisen M; Malhotra P
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760216
    [No Abstract]   [Full Text] [Related]  

  • 3. Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs.
    Bang G; Prieur E; Roussilhon C; Druilhe P
    PLoS One; 2011; 6(12):e28165. PubMed ID: 22145028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of antigenicity studies in humans.
    Demanga CG; Daher LJ; Prieur E; Blanc C; Pérignon JL; Bouharoun-Tayoun H; Druilhe P
    Infect Immun; 2010 Jan; 78(1):486-94. PubMed ID: 19884337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design.
    Singh S; Soe S; Mejia JP; Roussilhon C; Theisen M; Corradin G; Druilhe P
    J Infect Dis; 2004 Sep; 190(5):1010-8. PubMed ID: 15295710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum merozoite surface protein 6 displays multiple targets for naturally occurring antibodies that mediate monocyte-dependent parasite killing.
    Singh S; Soe S; Roussilhon C; Corradin G; Druilhe P
    Infect Immun; 2005 Feb; 73(2):1235-8. PubMed ID: 15664972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of immunogenicity studies in models.
    Daher LJ; Demanga CG; Prieur E; Pérignon JL; Bouharoun-Tayoun H; Druilhe P
    Infect Immun; 2010 Jan; 78(1):477-85. PubMed ID: 19581391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum merozoite surface protein 6 is a dimorphic antigen.
    Pearce JA; Triglia T; Hodder AN; Jackson DC; Cowman AF; Anders RF
    Infect Immun; 2004 Apr; 72(4):2321-8. PubMed ID: 15039357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.
    Osier FH; Polley SD; Mwangi T; Lowe B; Conway DJ; Marsh K
    Parasite Immunol; 2007 Aug; 29(8):387-94. PubMed ID: 17650180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes.
    Oeuvray C; Bouharoun-Tayoun H; Gras-Masse H; Bottius E; Kaidoh T; Aikawa M; Filgueira MC; Tartar A; Druilhe P
    Blood; 1994 Sep; 84(5):1594-602. PubMed ID: 8068948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
    Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC
    Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.
    Ibison F; Olotu A; Muema DM; Mwacharo J; Ohuma E; Kimani D; Marsh K; Bejon P; Ndungu FM
    PLoS One; 2012; 7(12):e52939. PubMed ID: 23300828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.
    Turner L; Wang CW; Lavstsen T; Mwakalinga SB; Sauerwein RW; Hermsen CC; Theander TG
    PLoS One; 2011; 6(12):e29025. PubMed ID: 22174947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.
    Theisen M; Soe S; Brunstedt K; Follmann F; Bredmose L; Israelsen H; Madsen SM; Druilhe P
    Vaccine; 2004 Mar; 22(9-10):1188-98. PubMed ID: 15003647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The origin and diversification of the merozoite surface protein 3 (msp3) multi-gene family in Plasmodium vivax and related parasites.
    Rice BL; Acosta MM; Pacheco MA; Carlton JM; Barnwell JW; Escalante AA
    Mol Phylogenet Evol; 2014 Sep; 78():172-84. PubMed ID: 24862221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of anti-MSP3 and Pfs230 antibody responses and multiplicity of infection in asymptomatic children from southern Ghana.
    Amoah LE; Acquah FK; Ayanful-Torgby R; Oppong A; Abankwa J; Obboh EK; Singh SK; Theisen M
    Parasit Vectors; 2018 Jan; 11(1):13. PubMed ID: 29304870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.
    Roussilhon C; Oeuvray C; Müller-Graf C; Tall A; Rogier C; Trape JF; Theisen M; Balde A; Pérignon JL; Druilhe P
    PLoS Med; 2007 Nov; 4(11):e320. PubMed ID: 18001147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.